The Clinical Measurement Ontology (CMO), Measurement Methods Ontology (MMO), and Experimental Condition Ontology (XCO) are currently being developed at the Rat Genome Database. For more information about these vocabularies please see Shimoyama et al. Three ontologies to define phenotype measurement data. Front Genet. 2012;3:87. Epub 2012 May 28 or contact us (http://rgd.mcw.edu/contact/index.shtml).
Term:
percentage of study population displaying leukemia at a point in time
The number of individuals in a study population which display leukemia, any of a group of progressive, malignant diseases of the blood-forming organs, marked by distorted proliferation and development of leukocytes and their precursors in the blood and bone marrow, at a certain point in time compared to the total number of individuals in the study population, expressed as a percentage.